Patents by Inventor Kirstin Wingler

Kirstin Wingler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation
    Patent number: 8236809
    Abstract: The invention relates to compounds of formula het-X-AB containing a N-heteroaryl moiety “het”, which is linked via X=sulfur to the 1,2,3-triazolo[4,5-d]pyrimidine-7-yl moiety AB of the formula (II). The invention also relates to a process for the preparation of said compounds and the use thereof in drugs for the treatment of NAD(P)H oxidase-related diseases and disorders and inhibition of platelet activation.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: August 7, 2012
    Assignee: Vasopharm GmbH
    Inventors: Frank Tegtmeier, Ulrich Walter, Reinhard Schinzel, Kirstin Wingler, Peter Scheurer, Harald Schmidt
  • Compounds Containing a N-Heteroaryl Moiety Linked to Fused Ring Moieties for the Inhibition of Nad(P)H Oxidases and Platelet Activation
    Publication number: 20080044354
    Abstract: The invention relates to compounds containing a N-heteroaryl moiety, which is linked via oxygen, sulfur or nitrogen, or via a methylene bridge and oxygen, sulfur or nitrogen to a fused ring moiety, in particular to the 1,2,3-triazolo[4,5d]pyrimidine-7-yl radical. The invention also relates to a process for the preparation of said compounds and the use thereof in drugs for the treatment of NAD(P)H oxidases-related diseases and disorders and inhibition of platelet activation.
    Type: Application
    Filed: May 13, 2005
    Publication date: February 21, 2008
    Inventors: Frank Tegtmeier, Ulrich Walter, Reinhard Schinzel, Kirstin Wingler, Peter Scheurer, Harald Schmidt